In an Issue Brief put out by the American Medical Association on June 18th, they stated, “More than 30 states have reported increases in opioid-related mortality as well as ongoing concerns for those with a mental illness or substance use disorder.”
During this webinar, Dr. Jill Warrington shared some of the early effects COVID-19 has had on the opioid crisis.
Jill Warrington MD, PhD
Chief Medical Officer
Aspenti Health™ and Clinical Faculty, University of Vermont